Novartis - Top 10 Layoffs of 2010

Company: Novartis
Layoffs: 1,400

Scoop: After much concern that Novartis would release Roche-esque layoffs, the company ended the year announcing 1,400 cuts from the sales department, all of which would be effective starting Jan. 1. The layoffs come primarily from the company's General Medicines sales force, as it prepares for the effects of numerous patent expirations. Instead, the company will focus its sales efforts on specialty drugs, according to a statement.

Novartis is still assessing its efficiency in sales, marketing and manufacturing, which could lead to more extensive job cuts in the coming years.

Novartis - Top 10 Layoffs of 2010
Read more on

Suggested Articles

With a brand new approval for Adakveo under its belt, Novartis Sunday flaunted an analysis showing the drug could cut patient hospitalizations by 40%.

BeiGene only just won its first Brukinsa nod in MCL. But it’s already pushing to join the CLL field, and Sunday it rolled out more data.

How long can one infusion of CAR-T drug Yescarta continue helping patients with refractory large B-cell lymphoma? Pretty long, Gilead showed Saturday.